News Notes

Biomedical scientists from 16 countries who are supported by the Howard Hughes Medical Institute's (HHMI) International Research Scholars program will meet as a group for the first time this month in Maryland. The meeting provides a forum for both technical presentations and discussions about how researchers in different parts of the world might work together more effectively. Since 1991 HHMI has awarded more than $53 million in five-year grants to 177 research scientists working at their home i

Written byNadia Halim
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Biomedical scientists from 16 countries who are supported by the Howard Hughes Medical Institute's (HHMI) International Research Scholars program will meet as a group for the first time this month in Maryland. The meeting provides a forum for both technical presentations and discussions about how researchers in different parts of the world might work together more effectively. Since 1991 HHMI has awarded more than $53 million in five-year grants to 177 research scientists working at their home institutions. "Science is moving so fast, especially in biology, that no part of the world should be left behind in this era of genomics and postgenomics. We [the United States] should ensure the research is being forwarded collaboratively, internationally," explains Joseph Perpich, vice president of grants and special programs. The program has primarily funded junior faculty, who are often the first to lose funding in countries that traditionally concentrate their limited resources on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies